STI Stock Trade Intelligence
SPL

STARPHARMA HOLDINGS LIMITED

Health Care · ASX:SPL
$0.4200
▼ -1.18%
Market cap
$203M
Turnover
$221,253
Last price
$0.4200
Day change
-1.18%
Announcements
15
Range, past year
Open 0.420 · Low 0.082 · Now 0.420 · High 0.875
Open SPL in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

SPL momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-11-16.
Momentum quality
31/100
Wyckoff phase
Accumulation6d
Trend stage
Neutral
1 Day
-1.2%
1 Week
-6.7%
1 Month
-44.0%
1 Year
+0.0%
RSI
28
Avg daily range
8.5%

STARPHARMA HOLDINGS LIMITED scores 31 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.

On the Wyckoff cycle it sits in Accumulation, where it has been for 6 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.

Against the wider market it is currently underperforming and the institutional accumulation signal reads low.

Points to watch
  • RSI oversold (28)
  • 60d drawdown -52.9%
  • High volatility (ATR 8.5%)
  • Risk rating: Very High
  • Composite downside risk elevated
SPL appears on this screen:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

SPL announcements

Recent price-sensitive releases.
  • 2026-11-06 AGM Chair address and CEO presentation Company Presentation | Chair's Address to Shareholders
  • 2026-10-22 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - First Quarter Activity Report | Commitments Test Entity - First Quarter Cashflow Report
  • 2026-10-20 Starpharma secures majority ownership of Petalion Web Cast | Trading Halt Lifted | Progress Report
  • 2026-10-16 Trading Halt Trading Halt
  • 2026-08-26 FY26 Key Financial Results and Annual Report Preliminary Final Report
  • 2026-08-26 Preliminary Final Report Preliminary Final Report
  • 2026-08-11 Successful Completion of $32 million Entitlement Offer Renounceable Issue
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.